Renal Scintigraphy: Split Function & GFR

Introduction

Renal scintigraphy exists to turn a dynamic image sequence into two numbers a clinician actually acts on: the split (relative) function of each kidney and the glomerular filtration rate. A renogram is not read by eye alone — it is quantified, and the quality of that quantification rests entirely on the physics of counting photons correctly.

That is where a nuclear medicine physicist earns their keep. The two clinical numbers — "the left kidney is 38% of total function" and "the camera-based GFR is 62 mL/min" — are the end of a chain that starts with region-of-interest counts, passes through background subtraction and kidney-depth attenuation correction, and ends with an empirical calibration. Get any link wrong and the numbers are wrong in ways that look perfectly plausible. ^{1, 3}

This guide walks through how split renal function and camera-based GFR are computed, the role of the radiotracer, the Gates method and its limits, and the quality-control factors that decide whether the numbers can be trusted. DRPS supports these programs through its PET/CT and nuclear medicine physics services across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Topic Explanation

What the renogram measures

A dynamic renal study injects a Tc-99m–labeled tracer intravenously and images the kidneys continuously with a gamma camera, usually posteriorly, generating a time–activity curve for each kidney: the renogram. The curve has three recognizable phases — a brief vascular (perfusion) phase, an uptake (parenchymal) phase as the tracer is extracted by the kidney, and an excretory phase as it drains into the collecting system and bladder. ¹

Two quantities are extracted from this sequence:

• Split (relative) renal function — how the total function divides between the two kidneys, measured during the uptake phase before drainage confounds the counts.
• Glomerular filtration rate (GFR) — an absolute measure of filtering capacity, which a gamma camera can estimate from the early fractional uptake of a glomerular agent. ^{1, 3}

Why it is not just a blood test

Serum creatinine and estimated GFR describe total kidney function. They cannot tell you which kidney is doing the work. When a patient has a possibly obstructed kidney, a potential living-donor evaluation, or a planned nephrectomy, the split matters — a kidney contributing 15% of function is a very different surgical conversation than one contributing 45%. Adding a diuretic further separates a truly obstructed system from a dilated but freely draining one, which is the core purpose of the SNMMI/EANM diuretic renography standard. ^{1, 2}

For related quantitative nuclear medicine work, see our guides on quantitative SPECT/CT calibration and dose calibrator quality control.

Key Technical Principles

Choosing the radiotracer

The tracer determines what the study can measure, because different agents are handled by the kidney by different mechanisms. ¹

MAG3 gives the cleanest dynamic curves, especially when function is poor, because its high extraction produces strong kidney counts against low background. DTPA, being a glomerular agent, is the physiologic choice when the goal is an absolute GFR. DMSA is a static cortical agent — the reference for split function and for detecting scarring — but it does not produce a renogram. ^{1, 3}

Split renal function: the counting problem

Split function is conceptually simple and practically demanding. During the uptake phase — commonly a 1 to 2.5 minute window after injection, before tracer reaches the renal pelvis — the counts in each kidney are proportional to that kidney's function. The relative function of the left kidney is:

$${\text{RF}}_L=\frac{(C_L-B_L)}{(C_L-B_L)+(C_R-B_R)}\times 100\%$$

where $C$ is the gross counts in the kidney region of interest (ROI) and $B$ is the counts in a paired background ROI, scaled to the kidney ROI area. The right kidney is $100\%-{\text{RF}}_L$. ^{1, 3}

The difficulty is entirely in $B$. Overlying and underlying soft-tissue activity contributes counts that are not the kidney's function, and the choice of background region — perirenal, subrenal, or a scaled paired region — measurably shifts the split. A worked example makes the sensitivity concrete. Suppose the left kidney ROI shows 20,000 gross counts and the right 24,000, and that per-kidney background is correctly scaled to 4,000 (left) and 6,000 (right) because the right kidney sits behind more soft tissue:

$${\text{RF}}_L=\frac{20000-4000}{(20000-4000)+(24000-6000)}\times 100\%=\frac{16000}{34000}\times 100\%\approx 47\%$$

If a single symmetric background of 5,000 counts were applied to both kidneys instead, the same acquisition would give $15000/(15000+19000)\approx 44\%$ — a shift of about three percentage points from the background method alone. In a borderline surgical case, that is not negligible, which is why consistent, standardized ROI and background methodology is a quality-control priority. ^{1, 3}

Kidney depth and attenuation

The kidneys lie several centimeters deep, so their 140 keV photons are attenuated by overlying tissue before reaching a posterior detector. Attenuation is exponential:

$$C_{\text{corr}}=C_{\text{meas}}{e}^{\mu d}$$

where $d$ is the kidney depth and $\mu$ is the linear attenuation coefficient of soft tissue at 140 keV — approximately 0.153 cm⁻¹, consistent with tabulated photon-attenuation data for tissue-equivalent material. ⁷ A deeper kidney is attenuated more, so without correction it appears less functional than an equally functional but shallower kidney. For a kidney at 7 cm depth:

$$e^{\mu d}=e^{0.153\times 7}=e^{1.071}\approx 2.92$$

Nearly two-thirds of the emitted photons are lost to attenuation before detection, and the correction factor nearly triples the measured counts. Because depth is usually estimated from patient weight and height (for example, via a standard weight/height regression) rather than measured, body habitus is a direct source of error — the main reason camera-based GFR loses accuracy at the extremes of body mass index. ^{4, 7} When left and right kidney depths differ, uncorrected attenuation also biases the split, so depth correction matters for both numbers.

Camera-based GFR: the Gates method

The Gates method converts the early fractional renal uptake of Tc-99m DTPA into an absolute GFR. In outline: the injected activity is quantified from pre- and post-injection syringe counts; the fraction of that activity accumulated by both kidneys over a defined early interval (commonly the second to third minute) is measured from the camera; each kidney's counts are background-subtracted and depth-corrected; and the resulting percent uptake is converted to GFR in mL/min through an empirically derived linear calibration originally validated against creatinine clearance. ³ The great advantage is that it needs only a few minutes of camera time and no blood samples. ³

Its limits are equally important. Camera-based GFR correlates well with reference plasma-clearance methods in patients of normal habitus but degrades at high or low BMI, where the depth estimate is least reliable — a study comparing Gates GFR against a single-plasma-sample method found good agreement at normal BMI but significant underestimation outside the normal range. ⁴ Newer approaches — combining dynamic imaging with plasma clearance, or dynamic SPECT/CT with measured attenuation — improve reproducibility and can outperform the planar Gates estimate of GFR. ^{5, 6} The practical stance is to treat camera-based GFR as a robust, repeatable functional estimate interpreted alongside its reference method, not as an exact clearance value. ^{3, 4}

Clinical Impact

Decisions that hinge on the split

Split function drives concrete decisions. In suspected obstruction, a declining relative function over serial studies is evidence that a dilated system is damaging the kidney and may warrant intervention. In living-donor evaluation, the split helps decide which kidney to procure, leaving the better kidney with the donor. Before nephrectomy for a diseased or tumor-bearing kidney, the split predicts the function that will remain. In each case the number, not just the picture, is what the surgical team weighs. ^{1, 2}

Obstruction versus dilatation

A dilated renal pelvis on ultrasound or CT does not by itself mean obstruction. Diuretic renography adds furosemide to force high urine flow: a truly obstructed system fails to wash out, while a capacious but unobstructed system drains promptly. The washout curve — quantified, not just eyeballed — is what separates the two, and it can prevent an unnecessary operation. This is the central use case of the SNMMI/EANM diuretic renography standard. ²

Following function over time

Because the quantification is reproducible when the methodology is standardized, serial renography can track a kidney over months or years. That longitudinal value depends on consistency: the same tracer, timing, ROI method, background method, and depth-correction approach each time. Drift in any of these masquerades as a change in the patient. ^{1, 3}

Practical Optimization Tips

A defensible renal quantification program controls the same handful of factors every time.

1. Keep the camera honest

Split function and GFR both assume the detector counts accurately and uniformly. Field uniformity, energy-peaking on the 140 keV Tc-99m photopeak, and sensitivity constancy are prerequisites; a non-uniform detector biases regional counts. Tie renal quantification to the camera's routine QC program. ¹

2. Standardize ROIs and background

Adopt one ROI and background convention and apply it identically to every study and every follow-up. Because background subtraction can move the split by a few percentage points, the method must not vary study to study or technologist to technologist. ^{1, 3}

3. Estimate depth deliberately

Use a consistent depth method — a validated weight/height formula, or measured depth from a lateral view or SPECT/CT when available. Recognize that at high or low BMI the estimate is weakest, and flag those studies as having wider uncertainty on absolute GFR. ^{3, 4}

4. Quantify the injected dose carefully

Camera-based GFR depends on knowing the activity that actually entered the patient. Measure pre- and post-injection syringe counts under reproducible geometry, and watch for infiltrated injections, which corrupt the uptake fraction. ³

5. Interpret against the reference method

Report camera-based GFR with the understanding that it is an estimate calibrated to a reference clearance technique. Where an exact GFR is clinically critical, a plasma-clearance measurement remains the reference. ^{3, 4}

Common pitfalls to avoid

• Letting the background region drift. It is the single largest controllable source of split-function error.
• Ignoring body habitus. Depth estimation — and therefore absolute GFR — is least reliable at BMI extremes.
• Mixing tracers or timings across follow-ups. Consistency is what makes serial studies interpretable.
• Trusting an infiltrated injection. A partial paravenous dose invalidates the uptake fraction used for GFR.
• Reading the picture without the numbers. The whole point of renal scintigraphy is the quantified split and washout.

Regulatory Considerations

Renal scintigraphy uses Tc-99m radiopharmaceuticals, which are byproduct material regulated by the NRC or an Agreement State under 10 CFR Part 35 (Medical Use of Byproduct Material) and Part 20 (radiation protection). The authorized user, the radiation safety officer, and the medical physicist share responsibility for dose measurement, radiopharmaceutical handling, and quality control. ⁸

Key frameworks:

• SNMMI/EANM Practice Guideline for Renal Scintigraphy in Adults — the consensus procedure standard for acquisition, processing, and quantification, reviewed on its fifth anniversary or sooner. ¹
• SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults 1.0 — the standard for diuretic renography and obstruction assessment. ²
• 10 CFR Part 35 — medical-use requirements governing the radiopharmaceutical, the authorized user, and the RSO. ⁸

Jurisdiction depends on location. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that license medical use of byproduct material under their own radiation-control programs, while Washington DC and Delaware are regulated directly by the NRC. A facility should confirm which authority issues and inspects its medical-use license. For the broader safety context, see our guides on radioactive material license support and written directives in nuclear medicine. ⁸

Frequently Asked Questions (FAQs)

What is split renal function on a renogram?

Split (or relative) renal function is the percentage of total kidney function contributed by each kidney, most often expressed as a left-versus-right split summing to 100%. It is measured from the uptake phase of a dynamic renogram, using background-subtracted counts in each kidney, typically 1 to 2.5 minutes after injection before the tracer drains into the collecting system.

How is camera-based GFR calculated?

Camera-based GFR uses the Gates method: the fraction of injected Tc-99m DTPA taken up by the kidneys over a defined early interval is measured from the gamma camera, corrected for background and for kidney depth attenuation, and converted to an absolute GFR in mL/min through an empirically derived calibration. It estimates GFR without blood sampling.

Why does kidney depth matter?

The kidneys sit several centimeters below the skin surface, so their 140 keV photons are attenuated by overlying tissue before reaching a posterior camera. Because attenuation is exponential with depth, a deeper kidney appears to have fewer counts than a shallower one of equal function. Depth correction restores the comparison, which is why body habitus affects camera-based GFR accuracy.

Which radiotracer is used for split function versus GFR?

Tc-99m MAG3 is a tubular agent with high extraction, preferred for renography and split function, especially in impaired kidneys. Tc-99m DTPA is a glomerular agent used for camera-based GFR because it is cleared by filtration. Tc-99m DMSA binds the cortex and is the best static agent for split function and scar detection.

How accurate is the Gates method?

Camera-based GFR correlates reasonably with reference plasma-clearance methods in patients of normal body habitus but tends to lose accuracy at the extremes of body mass index, where depth estimation is less reliable. It is best treated as a robust, repeatable functional estimate rather than an exact clearance measurement, and should be interpreted with the reference method in mind.

What quality-control factors most affect the numbers?

Accurate camera calibration and uniformity, correct region-of-interest and background placement, proper depth estimation, injected-dose measurement (pre- and post-injection syringe counts), and patient positioning all drive the result. Errors in background subtraction and depth correction are the most common sources of split-function and GFR error.

When is renal scintigraphy preferred over a blood test?

Serum creatinine and estimated GFR give total kidney function but cannot separate the two kidneys. Renal scintigraphy provides split function and, with a diuretic, distinguishes true obstruction from a dilated but non-obstructed system — information that guides surgical decisions and pre-donation or pre-nephrectomy planning.

Key Takeaways

• Two numbers drive the study. Split (relative) function and GFR are what clinicians act on, and both are quantified from counts, not read by eye.
• Background subtraction sets the split. The kidney ROI counts are dominated by the background choice; a small change in the background method moves the split by a few percentage points.
• Depth correction is exponential. With μ ≈ 0.153 cm⁻¹ at 140 keV, a 7 cm kidney needs a correction factor near 2.9 — so body habitus directly affects absolute GFR.
• Match the tracer to the question. MAG3 for dynamic function, DTPA for glomerular GFR, DMSA for static split function and scars.
• Gates GFR is an estimate. It is reproducible and useful but degrades at BMI extremes; interpret it against a reference clearance method.
• Consistency enables follow-up. Standardized tracer, timing, ROI, background, and depth methods are what make serial studies comparable.

Conclusion

Renal scintigraphy is a quantification task wearing an imaging coat. The picture matters, but the deliverable is a pair of numbers — split function and GFR — and those numbers are only as good as the counting physics behind them. Background subtraction, kidney-depth attenuation correction, camera calibration, and injected-dose measurement are where the accuracy is won or lost.

The strongest programs standardize every one of those factors, recognize where camera-based GFR is weakest, and interpret the estimate against its reference method. Done well, renal scintigraphy answers a question no blood test can — which kidney, how much, and is it obstructed — with numbers a surgical team can act on.

How DRPS Can Help

Diagnostic Radiation Physics Services supports nuclear medicine departments in making renal quantification reliable: gamma-camera QC and uniformity, energy-peaking and sensitivity constancy, dose-calibrator accuracy, and review of ROI, background, and depth-correction methodology, delivered through PET/CT and nuclear medicine physics and medical physicist consulting with radiation safety officer support.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A renogram is only as trustworthy as the counts behind it — and that is exactly where a medical physicist adds value.

Related Resources

• Quantitative SPECT/CT calibration
• Dose calibrator quality control
• Gamma camera collimator selection
• Written directives in nuclear medicine
• Radioactive material license guide
• PET/CT and nuclear medicine physics
• Medical physicist consulting

References

1. Blaufox MD, De Palma D, Taylor A, et al. The SNMMI and EANM practice guideline for renal scintigraphy in adults. Eur J Nucl Med Mol Imaging. 2018;45(12):2218-2228. doi:10.1007/s00259-018-4129-6. PubMed
2. Taylor AT, Brandon DC, de Palma D, et al. SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0. Semin Nucl Med. 2018;48(4):377-390. doi:10.1053/j.semnuclmed.2018.02.010. PubMed
3. Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol. 1982;138(3):565-570. doi:10.2214/ajr.138.3.565. PubMed
4. Nautiyal A, Mukherjee A, Mitra D, Chatterjee P, Roy A. Impact of body mass index on Gates method of glomerular filtration rate estimation: a comparative study with single plasma sample method. Indian J Nucl Med. 2019;34(1):19-23. doi:10.4103/ijnm.IJNM_112_18. PubMed
5. Pang X, Li F, Huang S, et al. A novel method for accurate quantification of split glomerular filtration rate using combination of Tc-99m-DTPA renal dynamic imaging and its plasma clearance. Dis Markers. 2021;2021:6643586. doi:10.1155/2021/6643586. PubMed
6. Spiliotopoulou M, Papathanasiou N, Łabieniec Ł, et al. 99mTc-DTPA dynamic SPECT/CT renogram in adults: feasibility and diagnostic benefit. Nucl Med Commun. 2024;45(8):673-682. doi:10.1097/MNM.0000000000001865. PubMed
7. National Institute of Standards and Technology. XCOM: Photon Cross Sections Database (mass attenuation coefficients for soft tissue). nist.gov
8. U.S. Nuclear Regulatory Commission. 10 CFR Part 35: Medical Use of Byproduct Material. ecfr.gov
9. International Atomic Energy Agency. Nuclear Medicine Physics: A Handbook for Teachers and Students. IAEA; 2014. iaea.org